These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 318944)

  • 41. Measurement of urine N-acetyl-beta-D-glucosaminidase with a centrifugal analyzer.
    Orsonneau JL; Blanchardie P; Lustenberger P; Bernard S
    Clin Chem; 1987 Apr; 33(4):616. PubMed ID: 3829408
    [No Abstract]   [Full Text] [Related]  

  • 42. More about determination of N-acetyl-beta-D-glucosaminidase activity in urine without pretreatment of samples.
    Jung K; Klotzek S
    Clin Chem; 1988 May; 34(5):1002. PubMed ID: 3370783
    [No Abstract]   [Full Text] [Related]  

  • 43. Assay of urinary N-acetyl-beta-glucosaminidase in a centrifugal analyzer.
    Powell SC; Scaro J; Wilson E; Shihabi ZK
    Clin Chem; 1983 Oct; 29(10):1717-9. PubMed ID: 6616815
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Activity of N-acetyl-beta-D-glucosaminidase, alpha-L-fucosidases and alpha-D-mannosidase in the urine of normal individuals and patients with renal disease.
    Price RG; Thorpe R; Tucker SM; Phillips NC
    Biochem Soc Trans; 1977; 5(1):248-50. PubMed ID: 892172
    [No Abstract]   [Full Text] [Related]  

  • 45. [Comparison of urinary N-acetyl-beta-D-glucosaminidase activity determined by using 24-hour and 2-hour urine].
    Uno E; Sano-Shiba K; Ida T; Sakurai S
    Rinsho Byori; 1986 May; 34(5):590-4. PubMed ID: 3761626
    [No Abstract]   [Full Text] [Related]  

  • 46. A note on the practical aspects of the assay of N-acetyl-beta-glucosaminidase in human urine.
    Wellwood JM; Price RG; Ellis BG; Thompson AE
    Clin Chim Acta; 1976 May; 69(1):85-91. PubMed ID: 1269157
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Kinetic rate assay of urinary N-acetyl-beta-D-glucosaminidase with 2-chloro-4-nitrophenyl-N-acetyl-beta-D-glucosaminide as substrate.
    Makise J; Saito E; Obuchi M; Kanayama M; Ichikawa K; Harakawa K; Yoshida K
    Clin Chem; 1988 Oct; 34(10):2140-3. PubMed ID: 3255304
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Detection of renal artery stenosis by measuring urinary N-acetyl-beta-D-glucosaminidase.
    Mansell MA; Jones NF; Ziroyannis PN; Tucker SM; Marson WS
    Br Med J; 1978 Feb; 1(6110):414-5. PubMed ID: 624037
    [No Abstract]   [Full Text] [Related]  

  • 49. [Dosage of N-acetyl-beta-D glucosaminidase in the surveillance of nephrotoxic antibiotic treatment. Preliminary results].
    Dupond JL; Leconte des Floris R; Gibey R; Henry JC
    Nouv Presse Med; 1977 May; 6(21):1881-2. PubMed ID: 876838
    [No Abstract]   [Full Text] [Related]  

  • 50. Spectrophotometric assay for urinary N-acetyl-beta-D-glucosaminidase activity.
    Horak E; Hopfer SM; Sunderman FW
    Clin Chem; 1981 Jul; 27(7):1180-5. PubMed ID: 7237781
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Use of renal enzymes to evaluate nephrotoxicity in lithium treated patients.
    Garvey MJ; Tuason VB; Blomquist CH; Hwang S
    Br J Psychiatry; 1982 Oct; 141():420-2. PubMed ID: 7171913
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Urinary N-acetyl-beta-D-glucosaminidase as an indicator of tubular damage in multiple myeloma.
    Coward RA; DeLamore IW; Mallick NP; Robinson LE
    Clin Chim Acta; 1984 Apr; 138(3):293-8. PubMed ID: 6426824
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Early warning of rejection?
    Wellwood JM; Ellis BG; Hall JH; Robinson DR; Thompson AE
    Br Med J; 1973 May; 2(5861):261-5. PubMed ID: 4574344
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Renal tolerance of aztreonam evaluated on the basis of the urinary excretion of N-acetyl-beta-glucosaminidase].
    Albertazzi A; Cappelli P; Di Paolo B; Evangelista M
    G Ital Chemioter; 1985; 32(2):419-21. PubMed ID: 3833581
    [No Abstract]   [Full Text] [Related]  

  • 55. Clinical significance of urinary N-acetyl-beta-D-glucosaminidase and alanine aminopeptidase.
    Hsu WS; Kao JT; Chen JS
    Taiwan Yi Xue Hui Za Zhi; 1989 Apr; 88(4):407-9. PubMed ID: 2571671
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Urinary N-acetyl-beta-D-glucosaminidase (NAG) as an indicator of renal disease.
    Price RG
    Curr Probl Clin Biochem; 1979; (9):150-63. PubMed ID: 446070
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Presence of serum and tissue forms of N-acetyl-beta-glucosaminidase in urine from patients with renal disease.
    Ellis BG; Tucker SM; Thompson AE; Price RG
    Clin Chim Acta; 1975 Oct; 64(2):195-202. PubMed ID: 1183035
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rate assays of N-acetyl-beta-D-glucosaminidase: some problems and fundamental principles.
    Price RG; Pócsi I; Richardson AC; Whiting PH
    Clin Chem; 1990 Jun; 36(6):1259-60. PubMed ID: 2357812
    [No Abstract]   [Full Text] [Related]  

  • 59. Levels of urinary N-acetyl-beta-D-glucosaminidase (NAG) activity versus arterial hypertension.
    Laterza G; Clemenzia G; Gentile V; Bassano F; Scibinetti F; Russo G
    Panminerva Med; 1984; 26(2):101-3. PubMed ID: 6483455
    [No Abstract]   [Full Text] [Related]  

  • 60. Analysis of urinary N-acetyl-beta-D-glucosaminidase isozyme in patients treated with gentamicin or cis-diammine dichloroplatinum (II).
    Aikawa A; Hata M; Nakamura H
    Dev Toxicol Environ Sci; 1986; 14():183-6. PubMed ID: 3829974
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.